Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 4, 2019
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent - 3-Year Outcomes From the HOST-ASSURE Randomized Clinical TrialChee Hae Kim, Kyung Woo Park, Jeehoon Kang, et al.Korean Circulation Journal|June 3, 2022
Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI"You-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.Korean Circulation Journal|February 7, 2022
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMIYou-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.Journal of the American College of Cardiology|May 13, 2014
A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trialKyung Woo Park, Si-Hyuck Kang, Hyun-Jae Kang, et al.Korean Circulation Journal|June 6, 2019
Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery DiseaseKeun Ho Park, Youngkeun Ahn, Young Youp Koh, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 16, 2023
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemiaHae Won Jung, Chang-Yeon Kim, Seung-Pyo Hong, et al.BMC Pharmacology & Toxicology|January 7, 2017
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemiaMoo-Yong Rhee, Taehoon Ahn, Kiyuk Chang, et al.Clinical Therapeutics|December 24, 2016
Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular RiskYoung-June Yang, Sang-Hak Lee, Byung Soo Kim, et al.Clinical Therapeutics|July 13, 2015
Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical TrialSang-Hoon Na, Hae-Young Lee, Sang Hong Baek, et al.Pageof 3